Context Therapeutics Inc. (CNTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 139.92M |
| Enterprise Value | 74.04M |
| P/E Ratio | -0.64 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.77 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.31 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1 |
| Return On Equity | -0.82 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -36.11M |
| Net Income | -36.12M |
| Diluted EPS | -0.38 |
Balance Sheet
| Total Cash | 42.99M |
| Total Cash/Share | 0.45 |
| Total Debt | 244,992 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 5.81 |
| Book Value Per Share | 0.4 |
Price History
| 52-Week Change | -71.85 |
| 52-Week High | 3.62 |
| 52-Week Low | 0.3 |
| Moving Average 50 Days | 0.45 |
| Moving Average 200 Days | 1.57 |
Statistics
| Average Volume | 1.94M |
| Shares Outstanding | 91.88M |
| % Held by Institutions | 66.23 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
